2023 is being hailed as a ‘break-out year for artificial intelligence’, and with the launch of Open-AI’s Chat GPT, Google’s Bard, DeepMind’s Sparrow, Anthropic AI’s ‘Claude’ and, now, Chat GPT-4, it might well be true.

Yesterday’s announcement that the government is creating a new Department for Science, Innovation & Technology comes at a crucial time for the British technology sector.

In the wake of its abrupt U-turn on zero-Covid, China signalled at Davos it was open for business and urged the world to abandon its ‘Cold War mentality’. However, the tech war is far from over. If anything, it’s intensifying.

The UK has all the ingredients it needs to be the de facto world leader in the development and application of AI. But we must start to think differently about the regulatory frameworks that these modern tech businesses are operating in.

The focus of the Autumn Statement was primarily about fixing the nation’s finances, but there were some announcements from the Chancellor that are important for the science and tech sector.

The government’s decision to block the sale of Britain’s largest semiconductor plant to a Chinese company should give us pause to reflect on the nation’s technology strategy as a whole.

As the country faces the potential of the longest recession since records began, Rishi Sunak and his cabinet are going to have to think critically about how we can get back to growth in the UK.

In November 2021, Darktrace, a company Invoke and I had started only eight years previously joined the FTSE100. It had a market cap of 5 Billion pounds and was a fast-growing international business. Its share price was up over 100% from its IPO of 250p in April 2021.

Mike Lynch delivered the Alan Turing Lecture at the Braemar Summit, providing insights into the changing technological landscape of Britain, the country’s place in the world, and how we can ensure top tech businesses don’t move abroad.

Mike Lynch writes for The International Business Times on the idea that led him to create Darktrace and how he helped to steer the business towards one of the most successful floats in the history of the City.

Hot on the heels of Darktrace’s IPO – which has gone from a share price of £2.50 to over £7 in a matter of weeks – SOPHiA GENETICS, a pioneering genomics business that Invoke backed in 2014, list on the NASDAQ market. 

In a special edition of The Spectator’s podcast, Dr Mike Lynch talks to Fraser Nelson about the British tech conundrum. Why do so many tech successes sell out to Americans, or go to America?

Mike Lynch shares his thoughts on the new world of cyber attacks and the role of modern technology and the state in fighting cyber criminals.

Dr Mike Lynch OBE FREng FRS writes for London First on the growth of Darktrace and what it’s recent IPO means for London’s stock exchange, economy, jobs and position on the world stage.

Dr Mike Lynch writes for City A.M. on what he learnt taking Darktrace from a clever idea on a Cambridge whiteboard to a multi-billion-pound IPO on the London Stock Exchange.

Read some key excerpts from Dr Mike Lynch’s conversation with Pi Capital about his tech background, Darktrace and its recent London listing.

Dr Mike Lynch discusses why the listing of Darktrace, a strategically important, independent UK cyber AI technology, shows the strength of our R&D and a roadmap to listing in London. Today is also a significant day for the UK capital markets.

Dr Mike Lynch writes for City A.M. to discuss the importance of statistician Reverend Thomas Bayes, who has played an important part in his life and, unbeknownst to many, an important part in all of our lives.

This week, Dr Mike Lynch OBE FREng FRS, Board Director at Luminance, speaks to the company’s newly appointed CEO, Eleanor Weaver, to discuss how the award-winning AI platform is disrupting the legal sector, the impact of the pandemic and Brexit on its business operations, and how the company is looking to scale in 2021. 

Dr Mike Lynch OBE FREng FRS writes for Tortoise Media’s Slow Views on the steps the UK must take if it is to achieve the ambition of becoming a Science Superpower, including adopting more forward-looking AI regulation and a realistic approach to public-sector investment in AI.